AZD0901
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AZD0901, covering 2026-02-12 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Effects of AZD0901 Monotherapy in Adult Participants With 2L+ Advanced or Metastatic Gastric or GEJ Adenocarcinoma Expressing CLDN18.2 [Phase 2]